117 related articles for article (PubMed ID: 34956225)
1. Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis.
Loftus TJ; Ungaro R; Dirain M; Efron PA; Mazer MB; Remy KE; Hotchkiss RS; Zhong L; Bacher R; Starostik P; Moldawer LL; Brakenridge SC
Front Immunol; 2021; 12():792448. PubMed ID: 34956225
[TBL] [Abstract][Full Text] [Related]
2. Neutrophilic Myeloid-Derived Suppressor Cells and Severity in SARS-CoV-2 Infection.
Omar MA; El Hawary R; Eldash A; Sadek KM; Soliman NA; Hanna MOF; Shawky SM
Lab Med; 2024 Mar; 55(2):153-161. PubMed ID: 37352143
[TBL] [Abstract][Full Text] [Related]
3. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.
Mairpady Shambat S; Gómez-Mejia A; Schweizer TA; Huemer M; Chang CC; Acevedo C; Bergada-Pijuan J; Vulin C; Hofmaenner DA; Scheier TC; Hertegonne S; Parietti E; Miroshnikova N; Wendel Garcia PD; Hilty MP; Buehler PK; Schuepbach RA; Brugger SD; Zinkernagel AS
PLoS Pathog; 2022 Jan; 18(1):e1010176. PubMed ID: 35007290
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression in Sepsis: Biomarkers and Specialized Pro-Resolving Mediators.
Padovani CM; Yin K
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255280
[TBL] [Abstract][Full Text] [Related]
5. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.
Reyes M; Filbin MR; Bhattacharyya RP; Sonny A; Mehta A; Billman K; Kays KR; Pinilla-Vera M; Benson ME; Cosimi LA; Hung DT; Levy BD; Villani AC; Sade-Feldman M; Baron RM; Goldberg MB; Blainey PC; Hacohen N
Sci Transl Med; 2021 Jun; 13(598):. PubMed ID: 34103408
[TBL] [Abstract][Full Text] [Related]
6. Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.
Marais C; Claude C; Semaan N; Charbel R; Barreault S; Travert B; Piloquet JE; Demailly Z; Morin L; Merchaoui Z; Teboul JL; Durand P; Miatello J; Tissières P;
Ann Intensive Care; 2021 Jul; 11(1):111. PubMed ID: 34259942
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte Activation Patterns in Hospitalized Children: Comparing SARS-CoV-2, Bacterial Infections, and Inflammatory Pathologies.
Domitien Payet L; Bedin AS; Desselas É; Marie-Jeanne C; Mollevi C; Malergue F; Bourgoin P; Van de Perre P; Tuaillon É; Jeziorski É
J Leukoc Biol; 2024 Apr; ():. PubMed ID: 38648502
[TBL] [Abstract][Full Text] [Related]
8. Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients.
Burnett CE; Okholm TLH; Tenvooren I; Marquez DM; Tamaki S; Munoz Sandoval P; Willmore A; ; Hendrickson CM; Kangelaris KN; Langelier CR; Krummel MF; Woodruff PG; Calfee CS; Erle DJ; Ansel KM; Spitzer MH
Immunity; 2022 Jul; 55(7):1284-1298.e3. PubMed ID: 35779527
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 envelope protein regulates innate immune tolerance.
Geanes ES; McLennan R; Pierce SH; Menden HL; Paul O; Sampath V; Bradley T
iScience; 2024 Jun; 27(6):109975. PubMed ID: 38827398
[TBL] [Abstract][Full Text] [Related]
10. Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational Study.
Barrios EA; Mazer MB; McGonagill P; Bergmann CB; Goodman MD; Gould R; Rao M; Polcz V; Davis R; Del Toro D; Dirain M; Dram A; Hale L; Heidarian M; Kucaba TA; Lanz JP; McCray A; Meszaros S; Miles S; Nelson C; Rocha I; Silva EE; Ungaro R; Walton A; Xu J; Zeumer-Spataro L; Drewry A; Liang M; Bible LE; Loftus T; Turnbull I; Efron PA; Remy KE; Brakenridge S; Badovinac VP; Griffith TS; Moldawer LL; Hotchkiss RS; Caldwell CC
medRxiv; 2023 Sep; ():. PubMed ID: 37745385
[TBL] [Abstract][Full Text] [Related]
11. Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis.
Avendaño-Ortiz J; Lozano-Rodríguez R; Martín-Quirós A; Maroun-Eid C; Terrón V; Valentín J; Montalbán-Hernández K; Ruiz de la Bastida F; García-Garrido MA; Cubillos-Zapata C; Del Balzo-Castillo Á; Aguirre LA; López-Collazo E
Heliyon; 2020 Dec; 6(12):e05635. PubMed ID: 33283062
[TBL] [Abstract][Full Text] [Related]
12. "Feed a Cold, Starve a Fever?" A Review of Nutritional Strategies in the Setting of Bacterial Versus Viral Infections.
Sankararaman S; Venegas C; Seth S; Palchaudhuri S
Curr Nutr Rep; 2024 Jun; 13(2):314-322. PubMed ID: 38587572
[TBL] [Abstract][Full Text] [Related]
13. Gene expression signatures in blood from a West African sepsis cohort define host response phenotypes.
Chenoweth JG; Colantuoni C; Striegel DA; Genzor P; Brandsma J; Blair PW; Krishnan S; Chiyka E; Fazli M; Mehta R; Considine M; Cope L; Knight AC; Elayadi A; Fox A; Hertzano R; Letizia AG; Owusu-Ofori A; Boakye I; Aduboffour AA; Ansong D; Biney E; Oduro G; Schully KL; Clark DV
Nat Commun; 2024 May; 15(1):4606. PubMed ID: 38816375
[TBL] [Abstract][Full Text] [Related]
14. The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes.
Piccioni A; Franza L; Rosa F; Candelli M; Covino M; Ferrara M; Volonnino G; Bertozzi G; Vittoria Zamponi M; Maiese A; Savioli G; Franceschi F; La Russa R
Infect Med (Beijing); 2023 Sep; 2(3):202-211. PubMed ID: 38073889
[TBL] [Abstract][Full Text] [Related]
15. Do not Miss the Diagnosis of Bacterial Sepsis in Infants With COVID-19.
Böncüoğlu E; Kiymet E; Yilmaz Çelebi M; Cem E; Gülderen M; Şahinkaya Ş; Bayram N; Devrim İ
Pediatr Infect Dis J; 2022 Jan; 41(1):e31-e32. PubMed ID: 34740996
[No Abstract] [Full Text] [Related]
16. During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant.
Cavaillon JM
Clin Rev Allergy Immunol; 2023 Oct; 65(2):183-187. PubMed ID: 37395985
[TBL] [Abstract][Full Text] [Related]
17. Single-cell landscape of immunological responses in elderly patients with sepsis.
He W; Yao C; Wang K; Duan Z; Wang S; Xie L
Immun Ageing; 2024 Jun; 21(1):40. PubMed ID: 38909272
[TBL] [Abstract][Full Text] [Related]
18. Chronic Critical Illness Elicits a Unique Circulating Leukocyte Transcriptome in Sepsis Survivors.
Darden DB; Ghita GL; Wang Z; Stortz JA; Lopez MC; Cox MC; Hawkins RB; Rincon JC; Kelly LS; Fenner BP; Ozrazgat-Baslanti T; Leeuwenburgh C; Bihorac A; Loftus TJ; Moore FA; Brakenridge SC; Baker HV; Bacher R; Mohr AM; Moldawer LL; Efron PA
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361995
[TBL] [Abstract][Full Text] [Related]
19. Deep Phenotyping of the Lipidomic Response in COVID and non-COVID Sepsis.
Meng H; Sengupta A; Ricciotti E; Mrčela A; Mathew D; Mazaleuskaya LL; Ghosh S; Brooks TG; Turner AP; Schanoski AS; Lahens NF; Tan AW; Woolfork A; Grant G; Susztak K; Letizia AG; Sealfon SC; Wherry EJ; Laudanski K; Weljie AM; Meyer NB; FitzGerald GA
bioRxiv; 2023 Jun; ():. PubMed ID: 37398323
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of the Leukocyte Signaling Landscape during Acute COVID-19.
Turnbull IR; Fuchs A; Remy KE; Kelly MP; Frazier EP; Ghosh S; Chang SW; Mazer M; Hess A; Leonard J; Hoofnagle M; Colonna M; Hotchkiss RS
Res Sq; 2021 Feb; ():. PubMed ID: 33619472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
